Tammy M. Holm
- Genetics top 1%
- Connective tissue disorders research 9
-
- Aortic Disease and Treatment Approaches 5
- Aortic aneurysm repair treatments 3
- Ferroptosis and cancer prognosis 2
- Cancer Research top 5%
- Immunology and Allergy top 5%
-
- Thyroid Cancer Diagnosis and Treatment 5
-
- Cancer Cells and Metastasis 2
-
- Autophagy in Disease and Therapy 2
-
- Thyroid and Parathyroid Surgery 2
Tammy M. Holm
25 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Genetics 1.6k
- Pulmonary and Respiratory Medicine 1.4k
- Cardiology and Cardiovascular Medicine 889
- Cancer Research 340
- Immunology and Allergy 120
Countries citing papers authored by Tammy M. Holm
This map shows the geographic impact of Tammy M. Holm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tammy M. Holm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tammy M. Holm more than expected).
Fields of papers citing papers by Tammy M. Holm
This network shows the impact of papers produced by Tammy M. Holm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tammy M. Holm. The network helps show where Tammy M. Holm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tammy M. Holm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 16 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 11 | |
| 10 | 2018 | 16 | |
| 11 | 2015 | 7 | |
| 12 | 2015 | 25 | |
| 13 | 2014 | 5 | |
| 14 | 2010 | 95 | |
| 15 | Abstract 4521: AT2 Signaling is a Positive Prognostic and Therapeutic Modifier of Marfan Syndrome: Lessons on the Inequality of ACEi and ARBs | 2009 | 4 |
| 16 | 2009 | 14 | |
| 17 | 2009 | 210 | |
| 18 | Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic statesbreakdown → | 2007 | 542 |
| 19 | 2006 | 3 | |
| 20 | 2006 | 70 |
About Tammy M. Holm
Tammy M. Holm is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 3.2k indexed citations. Recurring topics across this work include Connective tissue disorders research (9 papers), Aortic Disease and Treatment Approaches (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Aortic aneurysm repair treatments (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Cells and Metastasis (2 papers), Autophagy in Disease and Therapy (2 papers) and Thyroid and Parathyroid Surgery (2 papers). The work is most often cited by research in Genetics (1.6k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cardiology and Cardiovascular Medicine (889 citations). Tammy M. Holm has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Harry C. Dietz, Jennifer Habashi, Bart Loeys, Daniel P. Judge, Djahida Bedja, Francesco Ramirez, Ronald D. Cohn, David L. Huso, Christel van Erp and Florian Schoenhoff.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.